Indisulam
Tocris Bioscience, part of Bio-Techne | Catalog # 6782
Molecular glue; pre-mRNA splicing modulator
Key Product Details
Description
Molecular glue; pre-mRNA splicing modulator
Product Description
Indisulam is an acts as a molecular glue to induce proteosomal degradation of mRNA splicing factor RBM39 (also designated CAPERα, HCC1, FSAP59, and RNPC2), via binding to DCAF15. Acts as a pre-mRNA splicing modulator (SPLAMs; splicing inhibitor sulfonamides), causes aberrant pre-mRNA splicing. Suppresses proliferation of cancer cell lines. Reduces viability of HCT-116 cells (IC50 = 0.56 μM). Induces cell cycle arrest in the G1 phase in cancer cell lines. Also a high affinity carbonic anhydrase isozyme XII (hCA XII) inhibitor (Ki = 3.0-5.7 nM).Product Specifications
Molecular Weight
385.84
Formula
C14H12ClN3O4S2
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
N1-(3-Chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide
CAS Number
165668-41-7
PubChem ID
216468
InChI Key
SETFNECMODOHTO-UHFFFAOYSA-N
SMILES
NS(=O)(C1=CC=C(S(=O)(NC2=CC=CC3=C2NC=C3Cl)=O)C=C1)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 38.58 | 100 |
Preparing Stock Solutions
for Indisulam
The following data is based on the product molecular weight 385.84
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.59 mL | 12.96 mL | 25.92 mL |
| 5 mM | 0.52 mL | 2.59 mL | 5.18 mL |
| 10 mM | 0.26 mL | 1.30 mL | 2.59 mL |
| 50 mM | 0.05 mL | 0.26 mL | 0.52 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Vullo Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Bioorg.Med.Chem.Lett. 2005 PMID: 15686894
- Di Function, clinical application, and strategies of Pre-mRNA splicing in cancer. Cell Death Differ. 2018 PMID: 30464224
- Owa Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J.Med.Chem. 1999 PMID: 10508428
- Ozawa E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo. Eur.J.Cancer. 2001 PMID: 11677118
- Uehara Selective degradation of splicing factor CAPERa by anticancer sulfonamides. Nat.Chem.Biol. 2017 PMID: 28437394
- Han Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science 2017 PMID: 28302793
Product Specific Notices for Indisulam
For research use only
Loading...
Loading...